The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program ...
Dopamine rushes, withdrawals, and detoxes are trending among wellness gurus online. But experts say the science behind the ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Nicole LaBolle noticed a tremor in her arm in her '20s but blamed it on drinking too much coffee and a lack of sleep ...
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
The global Parkinson’s disease (PD) market is expected to grow to $7.9 billion by 2033 from $3.4 billion in 2023, according ...
Nicole LaBolle noticed a tremor in her arm in her '20s but blamed it on drinking too much coffee and a lack of sleep ...
The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results